Cargando…
Doxorubicin and Varlitinib Delivery by Functionalized Gold Nanoparticles Against Human Pancreatic Adenocarcinoma
The aim of this study was to develop drug delivery nanosystems based on pegylated gold nanoparticles (PEGAuNPs) for a combination against pancreatic cancer cells. Doxorubicin and varlitinib, an anthracycline and a tyrosine kinase inhibitor respectively, were conjugated with gold nanoparticles. The s...
Autores principales: | Coelho, Sílvia Castro, Reis, Daniel Pires, Pereira, Maria Carmo, Coelho, Manuel A. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920992/ https://www.ncbi.nlm.nih.gov/pubmed/31652942 http://dx.doi.org/10.3390/pharmaceutics11110551 |
Ejemplares similares
-
Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells
por: Coelho, Sílvia Castro, et al.
Publicado: (2018) -
Nanocarriers Based on Gold Nanoparticles for Epigallocatechin Gallate Delivery in Cancer Cells
por: Cunha, Lídia, et al.
Publicado: (2022) -
Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells
por: Liu, Chun-Yu, et al.
Publicado: (2019) -
In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines
por: Dokduang, Hasaya, et al.
Publicado: (2020) -
A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA
por: Yin, Feng, et al.
Publicado: (2015)